search
Back to results

Tecnis Eyhance Versus Rayner RayOne Study

Primary Purpose

Cataract Senile, Pseudophakia

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Intraocular lens
Sponsored by
Brighton and Sussex University Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract Senile focused on measuring cataract, intraocular lens, intermediate vision

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Patients undergoing routine cataract surgery with:

    • Patients with a symptomatic cataract,
    • Postoperative visual potential of 0.2 LogMAR or better
    • Corneal astigmatism ≤1.5D
    • Patients who are willing to participate in this study.

Exclusion Criteria:

  • Patients under the age of 18 years,
  • Eyes with any ocular comorbidity with cornea, uvea, retina or optic nerve, which may be detrimental to visual outcomes.
  • Abnormal corneal topography or any other co-existing retinal or cornea conditions, astigmatism outside the study range,
  • Unable to consent and unable to attend follow-up visits

Sites / Locations

  • Brighton & Sussex University Hospitals NHS TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Tecnis Eyhance

Rayner RayOne

Arm Description

Tecnis Eyhance hydrophobic IOL is a monofocal IOL with added advantage of slightly better unaided intermediate vision at 60 cms.

Rayner Rayone is a monofocal hydrophilic IOL which is not intended to give better unaided or near vision.

Outcomes

Primary Outcome Measures

Unaided distance visual acuity (UCDVA) (Uniocular and binocular)
Uniocular and binocular uncorrected distance vision will be measured at the follow ups.
Unaided intermediate visual acuity (UIVA) (uniocular and binocular)
Uniocular and binocular unaided intermediate vision will be measured at the follow ups

Secondary Outcome Measures

Best corrected distance LogMAR visual acuity (CDVA) (uniocular and binocular)
Uniocular and binocular best spectacle corrected distance vision will be measured at the follow ups
Manifest refraction (Diopters)
Sphere, cylinder and axis of the manifest refraction will be recorded at follow ups
Defocus Curves (Diopters)
Defocus curves will be plotted by adding + and - lenses to the manifest refraction
Distance correct intermediate LogMAR visual acuity (DCIVA) at 60 cm
Uniocular and binocular best spectacle corrected intermediate vision will be recorded at follow ups
Wavefront aberrometry using iTrace Tracey aberrometer (Internal and total higher order and lower order aberrations)(microns)
Aberrometry will be performed using iTrace machine (Tracy Technologies, USA) at all follow up visits
Quality of life outcomes assessment by the Catquest 9SF questionnaire
Patients will be requested to fill a questionnaire at all follow up visits
Glare and halos questionnaire on 1-4 Likert scale
(1= no glare and halos, 2= infrequent; 3 = frequent and 4 = continuous)

Full Information

First Posted
November 4, 2019
Last Updated
November 21, 2019
Sponsor
Brighton and Sussex University Hospitals NHS Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT04175951
Brief Title
Tecnis Eyhance Versus Rayner RayOne Study
Official Title
Visual and Optical Outcomes After Bilateral Implantation of Tecnis Eyhance Versus Rayner RayOne Aspheric in Patients Undergoing Routine Cataract Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
November 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 24, 2019 (Actual)
Primary Completion Date
May 24, 2020 (Anticipated)
Study Completion Date
October 24, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Brighton and Sussex University Hospitals NHS Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Cataract surgery involves replacing milky lens with a plastic intraocular lens. This plastic lens can be either monofocal (fixates for distance or near without glasses), extended depth of focus (EDOF)(fixates for intermediate and distance vision only without glasses) or multifocal lenses (fixates for distance, intermediate and near vision without glasses). However, EDOF and multifocal lenses are known to produce glare and halos. Tecnis Eyhance (Johnson & Johnson, USA) is a monofocal IOL which give added intermediate vision without employing EDOF or multifocal technology and hence induces no glare and halos. Whereas monofocal IOLs such as RayOne do not give intermediate vision. The objective is to assess visual and optical performance of Tecnis Eyhance versus Rayner RayOne in a prospective, randomized, comparative bilateral study. The proposed study will be the first study comparing the new technology monofocal Eyhance with conventional RayOne Rayner lens to assess the added benefits of Eyhance technology at multiple visits until 3 months after the surgery. Patients attending the clinics with cataracts will be invited to participate in this randomised study. They will be randomised to receive either Eyhance or RayOne in both eyes through surgeries performed not more than 2 weeks apart. The patients will be followed up at 1 and 3 months in the research clinic to assess the uniocular and binocular vision, spectacle prescription, a simple non-invasive scan to look at any distortions in the optics of the eye (wavefront aberrometry) and questionnaire for assessing subjective outcomes, glare and halos.
Detailed Description
Study design: Prospective, randomised, comparative study assessing visual and optical outcomes after bilateral implantation of the new Johnson & Johnson Tecnis Eyhance versus monofocal Rayner RayOne in patients undergoing routine cataract surgery. Methodology: Suitable patients with cataracts in both eyes will be identified from cataract assessment clinics. They will be invited to participate in the study by the research nurse and handed over the patient information sheet and a consent form. The PI will consent the patient for the participation. If they agree to participate, they will be give the dates for their surgeries on the same day. The patients can choose to have both eyes done on the same day or two eyes within 2 weeks based on the patients convenience. If they chose to participate in the study, then the patient will have additional tests performed on the day of their cataract assessment clinic. This will take an additional 40 minutes. On the day of the surgery, the patients will be randomised using a computer generated randomisation to receive either Tecnis Eyhance or the Rayner RayOne lens. They will have the same lens in both eyes. The patients will be invited for a research follow up visit at 1 (between 30-37 days after 2nd eye surgery) and 3 months (90-100 days after 2nd eye surgery) were simple research tests will performed including vision assessment and a scan. At preoperative visit and 3 months the patients will be asked to fill in a questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract Senile, Pseudophakia
Keywords
cataract, intraocular lens, intermediate vision

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Tecnis Eyhance
Arm Type
Active Comparator
Arm Description
Tecnis Eyhance hydrophobic IOL is a monofocal IOL with added advantage of slightly better unaided intermediate vision at 60 cms.
Arm Title
Rayner RayOne
Arm Type
Active Comparator
Arm Description
Rayner Rayone is a monofocal hydrophilic IOL which is not intended to give better unaided or near vision.
Intervention Type
Device
Intervention Name(s)
Intraocular lens
Intervention Description
Tecnis Eyhance is a monofocal IOL which give added intermediate vision without employing EDOF or multifocal technology and hence induces no glare and halos. Whereas monofocal IOLs such as RayOne do not give intermediate vision.
Primary Outcome Measure Information:
Title
Unaided distance visual acuity (UCDVA) (Uniocular and binocular)
Description
Uniocular and binocular uncorrected distance vision will be measured at the follow ups.
Time Frame
3 months postoperatively
Title
Unaided intermediate visual acuity (UIVA) (uniocular and binocular)
Description
Uniocular and binocular unaided intermediate vision will be measured at the follow ups
Time Frame
3 months postoperatively
Secondary Outcome Measure Information:
Title
Best corrected distance LogMAR visual acuity (CDVA) (uniocular and binocular)
Description
Uniocular and binocular best spectacle corrected distance vision will be measured at the follow ups
Time Frame
1 and 3 months postoperatively
Title
Manifest refraction (Diopters)
Description
Sphere, cylinder and axis of the manifest refraction will be recorded at follow ups
Time Frame
1 and 3 months postoperatively
Title
Defocus Curves (Diopters)
Description
Defocus curves will be plotted by adding + and - lenses to the manifest refraction
Time Frame
1 and 3 months postoperatively
Title
Distance correct intermediate LogMAR visual acuity (DCIVA) at 60 cm
Description
Uniocular and binocular best spectacle corrected intermediate vision will be recorded at follow ups
Time Frame
1 and 3 months postoperatively
Title
Wavefront aberrometry using iTrace Tracey aberrometer (Internal and total higher order and lower order aberrations)(microns)
Description
Aberrometry will be performed using iTrace machine (Tracy Technologies, USA) at all follow up visits
Time Frame
1 and 3 months postoperatively
Title
Quality of life outcomes assessment by the Catquest 9SF questionnaire
Description
Patients will be requested to fill a questionnaire at all follow up visits
Time Frame
1 and 3 months postoperatively
Title
Glare and halos questionnaire on 1-4 Likert scale
Description
(1= no glare and halos, 2= infrequent; 3 = frequent and 4 = continuous)
Time Frame
1 and 3 months postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients undergoing routine cataract surgery with: Patients with a symptomatic cataract, Postoperative visual potential of 0.2 LogMAR or better Corneal astigmatism ≤1.5D Patients who are willing to participate in this study. Exclusion Criteria: Patients under the age of 18 years, Eyes with any ocular comorbidity with cornea, uvea, retina or optic nerve, which may be detrimental to visual outcomes. Abnormal corneal topography or any other co-existing retinal or cornea conditions, astigmatism outside the study range, Unable to consent and unable to attend follow-up visits
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Wendam, RSN
Phone
01273696955
Ext
3115
Email
maria.wendam@nhs.net
First Name & Middle Initial & Last Name or Official Title & Degree
Sean Gallagher, BMedSci
Phone
01273696955
Ext
3115
Email
sean.gallagher5@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mayank Nanavaty, FRCOphth,PhD
Organizational Affiliation
Brighton and Sussex University Hospitals NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brighton & Sussex University Hospitals NHS Trust
City
Brighton
State/Province
Sussex
ZIP/Postal Code
BN2 5BF
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mayank Nanavaty
Phone
07947166134
Email
mayank.nanavaty@nhs.net

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35020542
Citation
Nanavaty MA, Ashena Z, Gallagher S, Borkum S, Frattaroli P, Barbon E. Visual Acuity, Wavefront Aberrations, and Defocus Curves With an Enhanced Monofocal and a Monofocal Intraocular Lens: A Prospective, Randomized Study. J Refract Surg. 2022 Jan;38(1):10-20. doi: 10.3928/1081597X-20211109-02. Epub 2022 Jan 1.
Results Reference
derived

Learn more about this trial

Tecnis Eyhance Versus Rayner RayOne Study

We'll reach out to this number within 24 hrs